Atlas Trials

Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator

Clinical trial NCT03131700 · WITHDRAWN

Trial details

NCT number
NCT03131700
Sponsor
TRPHARM
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2017-12-01
Primary completion
2018-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.